The most common CFTR mutation worldwide, with approximately 45.3% of CF patients in the United States—a three base pair deletion, ΔF508—results in abnormal folding, leading to its degradation by the proteasome and a lack of CFTR proteins to the apical cell membrane. This evidence concerns the gene CFTR and cystic fibrosis.